Medicare Enrolled

Dr. Maryana Liedke, DO

Neurology · Port Jefferson Station, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1010 ROUTE 112 STE 300, Port Jefferson Station, NY 11776
6313649119
In practice since 2013 (13 years)
NPI: 1386987956 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Liedke from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Liedke? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Liedke

Dr. Maryana Liedke is a neurology specialist in Port Jefferson Station, NY, with 13 years of NPI registration. Based on federal Medicare data, Dr. Liedke performed 531 Medicare services across 365 unique beneficiaries.

Between the years covered by Open Payments, Dr. Liedke received a total of $78,337 from 72 pharmaceutical and/or device companies across 930 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Liedke is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 43% volume in NY $78,337 industry payments

Medicare Practice Summary

Medicare Utilization ↗
531
Medicare services
Top 43% in NY for neurology
365
Unique beneficiaries
$95
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~41 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
191 $114 $1,225
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
182 $84 $878
Trigger point injection, 3 or more muscles
Injection of medication into three or more specific muscle trigger points to relieve pain.
40 $49 $539
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
38 $149 $1,996
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
33 $108 $1,106
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
26 $86 $720
Bupivacaine injection, 0.5 mg
An injection of bupivacaine, a local anesthetic, administered in a dose of 0.5 mg.
21 $0 $250
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$78,337
Total received (2018-2024)
Avg $11,191/year across 7 years
Top 9% in NY for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
72
Companies
930
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$37,331 (47.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$22,674 (28.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$18,331 (23.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$19,571
2023
$31,887
2022
$17,959
2021
$3,965
2020
$2,739
2019
$2,067
2018
$149

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Biogen, Inc.
$10,039
TG Therapeutics, Inc.
$5,171
EMD Serono, Inc.
$693
ABBVIE INC.
$683
Amgen Inc.
$537
Novartis Pharmaceuticals Corporation
$422
Genentech USA, Inc.
$377
ARGENX US, INC.
$271
Alexion Pharmaceuticals, Inc.
$261
Takeda Pharmaceuticals U.S.A., Inc.
$210
GENZYME CORPORATION
$199
SK Life Science, Inc.
$122
Lundbeck LLC
$95
PFIZER INC.
$71
Acorda Therapeutics, Inc
$50
PROTEGA PHARMACEUTIALS INC
$43
Celgene Corporation
$39
MITSUBISHI TANABE PHARMA AMERICA, INC.
$39
CATALYST PHARMACEUTICALS, INC.
$38
Vanda Pharmaceuticals Inc.
$32
Inspire Medical Systems, Inc.
$28
Lilly USA, LLC
$27
Microtransponder, Inc.
$25
Otsuka America Pharmaceutical, Inc.
$22
ANI Pharmaceuticals, Inc.
$21
Harmony Biosciences Llc
$20
Merz Pharmaceuticals, LLC
$19
ACADIA Pharmaceuticals Inc
$15
Top 3 companies account for 81.3% of 2024 payments
All-time payments by company (2018-2024) ›
Biogen, Inc.
$38,475
EMD Serono, Inc.
$12,630
Genentech USA, Inc.
$6,514
TG Therapeutics, Inc.
$5,171
ABBVIE INC.
$2,637
Amgen Inc.
$1,001
Novartis Pharmaceuticals Corporation
$956
GENZYME CORPORATION
$908
UCB, Inc.
$735
Biohaven Pharmaceuticals, Inc.
$720
Allergan, Inc.
$665
Lundbeck LLC
$524
SK Life Science, Inc.
$505
Horizon Therapeutics plc
$443
Celgene Corporation
$417
Harmony Biosciences LLC
$392
ARGENX US, INC.
$366
Amneal Pharmaceuticals LLC
$361
Alexion Pharmaceuticals, Inc.
$332
Biohaven Pharmaceutical Holding Company Ltd.
$325
Lilly USA, LLC
$325
E.R. Squibb & Sons, L.L.C.
$287
AbbVie Inc.
$263
Acorda Therapeutics, Inc
$239
Takeda Pharmaceuticals U.S.A., Inc.
$228
SCILEX PHARMACEUTICALS INC.
$223
Supernus Pharmaceuticals, Inc.
$198
HARMONY BIOSCIENCES LLC
$185
Neurocrine Biosciences, Inc.
$154
Teva Pharmaceuticals USA, Inc.
$149
PFIZER INC.
$145
TG THERAPEUTICS, INC.
$143
Janssen Scientific Affairs, LLC
$127
Janssen Biotech, Inc.
$118
CSL Behring
$116
JAZZ PHARMACEUTICALS INC.
$99
UPSHER-SMITH LABORATORIES LLC
$96
Currax Pharmaceuticals LLC
$82
Almatica Pharma LLC
$67
Upsher-Smith Laboratories LLC
$67
Scilex Pharmaceuticals Inc.
$62
Janssen Pharmaceuticals, Inc
$61
ARBOR PHARMACEUTICALS, INC.
$58
Jazz Pharmaceuticals Inc.
$56
Medtronic, Inc.
$50
PROTEGA PHARMACEUTIALS INC
$43
MITSUBISHI TANABE PHARMA AMERICA, INC.
$39
CATALYST PHARMACEUTICALS, INC.
$38
Allergan Inc.
$37
Assertio Therapeutics, Inc.
$35
Neuronetics, Inc.
$32
Vanda Pharmaceuticals Inc.
$32
Avanir Pharmaceuticals, Inc.
$32
Bausch Health US, LLC
$30
ACADIA Pharmaceuticals Inc
$28
Inspire Medical Systems, Inc.
$28
Microtransponder, Inc.
$25
Mallinckrodt Hospital Products Inc.
$22
Otsuka America Pharmaceutical, Inc.
$22
ANI Pharmaceuticals, Inc.
$21
Harmony Biosciences Llc
$20
Merz Pharmaceuticals, LLC
$19
BANNER LIFE SCIENCES, LLC
$18
Merck Sharp & Dohme Corporation
$18
Collegium Pharmaceutical, Inc.
$17
ASSERTIO THERAPEUTICS, Inc.
$16
Alfasigma USA, Inc.
$16
Genentech, Inc.
$16
FORTE BIO-PHARMA LLC
$16
Neurelis, Inc.
$13
Kowa Pharmaceuticals America, Inc.
$12
Promius Pharma LLC
$11
Top 3 companies account for 73.6% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AUBAGIO · AVONEX · Aimovig · BAFIERTAM · BELSOMRA · BOTOX · BRIUMVI · Briviact · CAMBIA · CONTRAVE · Cenobamate · DUEXIS · EMGALITY · Enspryng · Evobrutinib · GILENYA · GRALISE · Gralise · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · INSPIRE · KESIMPTA · LEMTRADA · LILETTA · LINZESS · MAVENCLAD · MIGRANAL · Mavenclad · NAPRELAN · NEUROSTAR TMS THERAPY · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · OCREVUS · ONZETRA XSAIL · Ocrevus · Ocrevus Zunovo · Ongentys · PERCEPT PC BRAINSENSE · PLEGRIDY · PONVORY · PROLATE · PURIFIED CORTROPHIN GEL · Prolia · QUDEXY XR TOPIRAMATE EXTENDED RELEASE CAPSULES · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · RADICAVA · REXULTI · RINVOQ · ROXYBOND · RYTARY · Rebif · SIMPONI ARIA · SKYRIZI · SOLIRIS · SUNOSI · Seglentis · TAVNEOS · TECFIDERA · TOSYMRA · TREMFYA · TROKENDI XR · TYSABRI · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XCOPRI · XTAMPZA · XYREM · XYWAV · Xeomin · ZEMBRACE SYMTOUCH · ZEMBRACE SYMTOUCH SUMATRIPTAN INJECTION · ZEPOSIA · ZOMIG · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (48%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 9% for neurology in NY.

Looking for a neurology specialist in Port Jefferson Station?
Compare neurologists in the Port Jefferson Station area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
144
Per 100K population
9.4
County median income
$128,329
Nearest hospital
JOHN T MATHER MEMORIAL HOSPITAL OF PORT JEFFERSON
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Liedke is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 9% of NY peers.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Liedke experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Liedke performed 191 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Liedke receive payments from pharmaceutical companies?
Yes. Dr. Liedke received a total of $78,337 from 72 companies across 930 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Liedke's costs compare to other neurologists in Port Jefferson Station?
Dr. Liedke's average Medicare payment per service is $95. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Liedke) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →